Peli1 Modulates the Subcellular Localization and Activity of Mdmx
Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and re...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 78; no. 11; pp. 2897 - 2910 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research, Inc
01.06.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx–p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.
Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897–910. ©2018 AACR. |
---|---|
AbstractList | Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers.Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx–p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897–910. ©2018 AACR. Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897-910. ©2018 AACR.Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897-910. ©2018 AACR. Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers. Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx–p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers. Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897–910. ©2018 AACR. Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx and and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers. Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. . |
Author | Li, Dawei Sun, Shao-Cong Gu, Wei Tavana, Omid |
AuthorAffiliation | 1 Institute for Cancer Genetics, Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, HICCC Building, Rm#609, 1130 St. Nicholas Ave, New York, NY 10032, USA 2 Department of Immunology, The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 7455 Fannin Street, Box 902, Houston, Texas 77030, USA |
AuthorAffiliation_xml | – name: 1 Institute for Cancer Genetics, Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, HICCC Building, Rm#609, 1130 St. Nicholas Ave, New York, NY 10032, USA – name: 2 Department of Immunology, The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 7455 Fannin Street, Box 902, Houston, Texas 77030, USA |
Author_xml | – sequence: 1 givenname: Dawei surname: Li fullname: Li, Dawei – sequence: 2 givenname: Omid surname: Tavana fullname: Tavana, Omid – sequence: 3 givenname: Shao-Cong surname: Sun fullname: Sun, Shao-Cong – sequence: 4 givenname: Wei surname: Gu fullname: Gu, Wei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29523541$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkVFLHDEUhYNYdNX-BMtAX3wZm5vJnSQUCstSa2FthbbPIZPJ1MjsxE4yUv31zahdrC99Csn9zuWcnAOyO4TBEXIM9BQA5TtKqSyRC3a6Wn4pQZQVVrBDFoCVLAXnuEsWW2afHMR4na8IFPfIPlPIKuSwIMtL13soLkI79Sa5WKQrV3ybGuv6Pr-MxTpY0_t7k3wYCjO0xdImf-vTXRG64qLd_D4irzrTR_f66TwkP84-fl-dl-uvnz6vluvS8kql0kBtalpL0XAKrLUIdcfqxrQKa8x-OoGN4rarrBAgjO2YkkxQ5ZirG0RXHZIPj3tvpmbjWuuGNJpe34x-Y8Y7HYzX_04Gf6V_hluNSvJaQV5w8rRgDL8mF5Pe-DjnNIMLU9Qs-1LAJKiMvn2BXodpHHK8THGBCqSQmXrz3NHWyt_fzQA-AnYMMY6u2yJA9dyinhvSc0M6t6hB6LnFrHv_Qmd9emggB_P9f9R_AMbQoOM |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_728794 crossref_primary_10_1016_j_celrep_2023_112833 crossref_primary_10_3390_cells10102529 crossref_primary_10_1111_jcmm_14878 crossref_primary_10_1074_jbc_RA118_007150 crossref_primary_10_1021_acs_jmedchem_4c00913 crossref_primary_10_1093_jmcb_mjz007 crossref_primary_10_15252_embj_2020104410 crossref_primary_10_2147_BTT_S436629 crossref_primary_10_1016_j_isci_2022_105115 crossref_primary_10_1016_j_cellsig_2024_111194 crossref_primary_10_1016_j_pathol_2023_10_020 crossref_primary_10_1101_gad_347872_120 crossref_primary_10_1016_j_bbrc_2019_03_095 crossref_primary_10_1038_s41389_023_00457_3 |
Cites_doi | 10.1016/j.molcel.2011.08.020 10.1093/jmcb/mjx001 10.1177/1947601912454733 10.1101/gad.13.20.2658 10.1016/j.molcel.2006.01.020 10.1158/1078-0432.CCR-05-0683 10.1002/humu.22524 10.1097/CCO.0000000000000033 10.1016/j.cell.2009.04.037 10.1074/jbc.M113.476606 10.1038/sj.onc.1208052 10.1042/BJ20071365 10.1074/jbc.M704558200 10.1242/jcs.03362 10.1074/jbc.M805658200 10.1111/imr.12298 10.1126/science.1091362 10.1093/jmcb/mjx004 10.1038/sj.emboj.7601465 10.1038/sj.emboj.7601469 10.1074/jbc.M212112200 10.1128/MCB.22.21.7562-7571.2002 10.1111/imr.12306 10.1073/pnas.95.14.8292 10.1002/humu.10185 10.1101/gad.12.15.2424 10.1101/gad.13.20.2670 10.1177/1947601912455324 10.1038/nri3599 10.1016/j.ccr.2009.05.008 10.1038/sj.onc.1210788 10.1016/j.canlet.2013.12.025 10.1016/j.cell.2005.03.037 10.1073/pnas.1102241108 10.1128/MCB.00555-06 10.1038/378203a0 10.1084/jem.167.2.353 10.1158/0008-5472.CAN-07-1313 10.1038/nm.2863 10.1016/j.cell.2009.04.050 10.1172/JCI75667 10.1002/jcb.21091 10.1038/ni.1777 10.1038/nrc3430 |
ContentType | Journal Article |
Copyright | 2018 American Association for Cancer Research. Copyright American Association for Cancer Research, Inc. Jun 1, 2018 |
Copyright_xml | – notice: 2018 American Association for Cancer Research. – notice: Copyright American Association for Cancer Research, Inc. Jun 1, 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 8FD FR3 H94 P64 RC3 7X8 5PM |
DOI | 10.1158/0008-5472.CAN-17-3531 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Genetics Abstracts MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 2910 |
ExternalDocumentID | PMC5984691 29523541 10_1158_0008_5472_CAN_17_3531 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: T32 CA009503 – fundername: NCI NIH HHS grantid: R01 CA190477 – fundername: NCI NIH HHS grantid: R01 CA193890 – fundername: NCI NIH HHS grantid: R01 CA085533 – fundername: NCI NIH HHS grantid: R01 CA216884 |
GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 53G 5GY 5RE 5VS 6J9 AAFWJ AAJMC AAYXX ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AETEA AFHIN AFOSN AFRAH AFUMD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 8FD FR3 H94 P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c439t-a16a60687b4012dc516f26bad9565295f75b94cf3c7717acf2982709e2e6b55e3 |
ISSN | 0008-5472 1538-7445 |
IngestDate | Thu Aug 21 18:36:25 EDT 2025 Fri Jul 11 00:30:47 EDT 2025 Sun Jul 13 04:35:54 EDT 2025 Mon Jul 21 05:52:05 EDT 2025 Tue Jul 01 01:19:27 EDT 2025 Thu Apr 24 23:06:37 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | 2018 American Association for Cancer Research. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c439t-a16a60687b4012dc516f26bad9565295f75b94cf3c7717acf2982709e2e6b55e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://cancerres.aacrjournals.org/content/canres/78/11/2897.full.pdf |
PMID | 29523541 |
PQID | 2047591878 |
PQPubID | 105549 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984691 proquest_miscellaneous_2012912819 proquest_journals_2047591878 pubmed_primary_29523541 crossref_primary_10_1158_0008_5472_CAN_17_3531 crossref_citationtrail_10_1158_0008_5472_CAN_17_3531 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-06-01 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 06 year: 2018 text: 2018-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Baltimore |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationTitleAlternate | Cancer Res |
PublicationYear | 2018 |
Publisher | American Association for Cancer Research, Inc |
Publisher_xml | – name: American Association for Cancer Research, Inc |
References | Wang (2022061706173794000_bib44) 2008; 27 Helton (2022061706173794000_bib3) 2007; 100 Chang (2022061706173794000_bib24) 2009; 10 Eischen (2022061706173794000_bib41) 1999; 13 Talantov (2022061706173794000_bib25) 2005; 11 Brooks (2022061706173794000_bib13) 2006; 21 Moynagh (2022061706173794000_bib29) 2014; 14 Zindy (2022061706173794000_bib39) 1998; 12 Kawai (2022061706173794000_bib15) 2007; 67 Kruse (2022061706173794000_bib1) 2009; 137 Butler (2022061706173794000_bib31) 2007; 282 Park (2022061706173794000_bib36) 2014; 124 Humphries (2022061706173794000_bib37) 2015; 266 Eischen (2022061706173794000_bib7) 2014; 35 Montes de Oca Luna (2022061706173794000_bib11) 1995; 378 Li (2022061706173794000_bib14) 2003; 302 Ordureau (2022061706173794000_bib30) 2008; 409 Gannon (2022061706173794000_bib5) 2012; 3 Chen (2022061706173794000_bib21) 2005; 121 Kruse (2022061706173794000_bib35) 2009; 284 Wang (2022061706173794000_bib33) 2009; 16 Harris (2022061706173794000_bib38) 1998; 167 Wade (2022061706173794000_bib8) 2013; 13 Li (2022061706173794000_bib22) 2011; 43 Poyurovsky (2022061706173794000_bib16) 2007; 26 Marine (2022061706173794000_bib12) 2007; 120 Uldrijan (2022061706173794000_bib17) 2007; 26 Li (2022061706173794000_bib34) 2002; 22 Jochemsen (2022061706173794000_bib20) 2014; 26 Vousden (2022061706173794000_bib2) 2009; 137 Chen (2022061706173794000_bib9) 2012; 3 Kamijo (2022061706173794000_bib40) 1998; 95 Pant (2022061706173794000_bib18) 2011; 108 Moyer (2022061706173794000_bib19) 2017 Medvedev (2022061706173794000_bib28) 2015; 266 Gembarska (2022061706173794000_bib26) 2012; 18 Eischen (2022061706173794000_bib43) 2004; 23 Liu (2022061706173794000_bib4) 2015; 356 Zhou (2022061706173794000_bib10) 2017; 9 Schmitt (2022061706173794000_bib42) 1999; 13 Varley (2022061706173794000_bib6) 2003; 21 Terzian (2022061706173794000_bib32) 2007; 27 Dai (2022061706173794000_bib23) 2013; 288 Jiang (2022061706173794000_bib27) 2003; 278 |
References_xml | – volume: 43 start-page: 1023 year: 2011 ident: 2022061706173794000_bib22 article-title: A critical role for noncoding 5S rRNA in regulating Mdmx stability publication-title: Mol Cell doi: 10.1016/j.molcel.2011.08.020 – volume: 9 start-page: 62 year: 2017 ident: 2022061706173794000_bib10 article-title: Negative auto-regulators trap p53 in their web publication-title: J Mol Cell Biol doi: 10.1093/jmcb/mjx001 – volume: 3 start-page: 274 year: 2012 ident: 2022061706173794000_bib9 article-title: The roles of MDM2 and MDMX phosphorylation in stress signaling to p53 publication-title: Genes Cancer doi: 10.1177/1947601912454733 – volume: 13 start-page: 2658 year: 1999 ident: 2022061706173794000_bib41 article-title: Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis publication-title: Genes Dev doi: 10.1101/gad.13.20.2658 – volume: 21 start-page: 307 year: 2006 ident: 2022061706173794000_bib13 article-title: p53 ubiquitination: Mdm2 and beyond publication-title: Mol Cell doi: 10.1016/j.molcel.2006.01.020 – volume: 11 start-page: 7234 year: 2005 ident: 2022061706173794000_bib25 article-title: Novel genes associated with malignant melanoma but not benign melanocytic lesions publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0683 – volume: 35 start-page: 728 year: 2014 ident: 2022061706173794000_bib7 article-title: The Mdm network and its regulation of p53 activities: a rheostat of cancer risk publication-title: Hum Mutat doi: 10.1002/humu.22524 – volume: 26 start-page: 114 year: 2014 ident: 2022061706173794000_bib20 article-title: Reactivation of p53 as therapeutic intervention for malignant melanoma publication-title: Curr Opin Oncol doi: 10.1097/CCO.0000000000000033 – volume: 137 start-page: 413 year: 2009 ident: 2022061706173794000_bib2 article-title: Blinded by the light: the growing complexity of p53 publication-title: Cell doi: 10.1016/j.cell.2009.04.037 – volume: 288 start-page: 19581 year: 2013 ident: 2022061706173794000_bib23 article-title: Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1) publication-title: J Biol Chem doi: 10.1074/jbc.M113.476606 – volume: 23 start-page: 8931 year: 2004 ident: 2022061706173794000_bib43 article-title: Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development publication-title: Oncogene doi: 10.1038/sj.onc.1208052 – volume: 409 start-page: 43 year: 2008 ident: 2022061706173794000_bib30 article-title: The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1 publication-title: Biochem J doi: 10.1042/BJ20071365 – volume: 282 start-page: 29729 year: 2007 ident: 2022061706173794000_bib31 article-title: Kinase-active interleukin-1 receptor-associated kinases promote polyubiquitination and degradation of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-protein isopeptide ligases publication-title: J Biol Chem doi: 10.1074/jbc.M704558200 – volume: 120 start-page: 371 year: 2007 ident: 2022061706173794000_bib12 article-title: MDMX: from bench to bedside publication-title: J Cell Sci doi: 10.1242/jcs.03362 – volume: 284 start-page: 3250 year: 2009 ident: 2022061706173794000_bib35 article-title: MSL2 promotes Mdm2-independent cytoplasmic localization of p53 publication-title: J Biol Chem doi: 10.1074/jbc.M805658200 – volume: 266 start-page: 109 year: 2015 ident: 2022061706173794000_bib28 article-title: E3 ubiquitin ligases Pellinos as regulators of pattern recognition receptor signaling and immune responses publication-title: Immunol Rev doi: 10.1111/imr.12298 – volume: 302 start-page: 1972 year: 2003 ident: 2022061706173794000_bib14 article-title: Mono- versus polyubiquitination: differential control of p53 fate by Mdm2 publication-title: Science doi: 10.1126/science.1091362 – year: 2017 ident: 2022061706173794000_bib19 article-title: Mdm proteins: critical regulators of embry ogenesis and homeostasis publication-title: J Mol Cell Biol doi: 10.1093/jmcb/mjx004 – volume: 26 start-page: 90 year: 2007 ident: 2022061706173794000_bib16 article-title: The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity publication-title: EMBO J doi: 10.1038/sj.emboj.7601465 – volume: 26 start-page: 102 year: 2007 ident: 2022061706173794000_bib17 article-title: An essential function of the extreme C-terminus of MDM2 can be provided by MDMX publication-title: EMBO J doi: 10.1038/sj.emboj.7601469 – volume: 278 start-page: 10952 year: 2003 ident: 2022061706173794000_bib27 article-title: Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex publication-title: J Biol Chem doi: 10.1074/jbc.M212112200 – volume: 22 start-page: 7562 year: 2002 ident: 2022061706173794000_bib34 article-title: DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms publication-title: Mol Cell Biol doi: 10.1128/MCB.22.21.7562-7571.2002 – volume: 266 start-page: 93 year: 2015 ident: 2022061706173794000_bib37 article-title: Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity publication-title: Immunol Rev doi: 10.1111/imr.12306 – volume: 95 start-page: 8292 year: 1998 ident: 2022061706173794000_bib40 article-title: Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.14.8292 – volume: 21 start-page: 313 year: 2003 ident: 2022061706173794000_bib6 article-title: Germline TP53 mutations and Li-Fraumeni syndrome publication-title: Hum Mutat doi: 10.1002/humu.10185 – volume: 12 start-page: 2424 year: 1998 ident: 2022061706173794000_bib39 article-title: Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization publication-title: Genes Dev doi: 10.1101/gad.12.15.2424 – volume: 13 start-page: 2670 year: 1999 ident: 2022061706173794000_bib42 article-title: INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53 publication-title: Genes Dev doi: 10.1101/gad.13.20.2670 – volume: 3 start-page: 209 year: 2012 ident: 2022061706173794000_bib5 article-title: Using mouse models to explore MDM-p53 signaling in development, cell growth, and tumorigenesis publication-title: Genes Cancer doi: 10.1177/1947601912455324 – volume: 14 start-page: 122 year: 2014 ident: 2022061706173794000_bib29 article-title: The roles of Pellino E3 ubiquitin ligases in immunity publication-title: Nat Rev Immunol doi: 10.1038/nri3599 – volume: 16 start-page: 33 year: 2009 ident: 2022061706173794000_bib33 article-title: Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.05.008 – volume: 27 start-page: 1590 year: 2008 ident: 2022061706173794000_bib44 article-title: Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells publication-title: Oncogene doi: 10.1038/sj.onc.1210788 – volume: 356 start-page: 197 year: 2015 ident: 2022061706173794000_bib4 article-title: Tumor suppressor p53 and its mutants in cancer metabolism publication-title: Cancer Lett doi: 10.1016/j.canlet.2013.12.025 – volume: 121 start-page: 1071 year: 2005 ident: 2022061706173794000_bib21 article-title: ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor publication-title: Cell doi: 10.1016/j.cell.2005.03.037 – volume: 108 start-page: 11995 year: 2011 ident: 2022061706173794000_bib18 article-title: Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1102241108 – volume: 27 start-page: 5479 year: 2007 ident: 2022061706173794000_bib32 article-title: Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development publication-title: Mol Cell Biol doi: 10.1128/MCB.00555-06 – volume: 378 start-page: 203 year: 1995 ident: 2022061706173794000_bib11 article-title: Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 publication-title: Nature doi: 10.1038/378203a0 – volume: 167 start-page: 353 year: 1998 ident: 2022061706173794000_bib38 article-title: The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells publication-title: J Exp Med doi: 10.1084/jem.167.2.353 – volume: 67 start-page: 6026 year: 2007 ident: 2022061706173794000_bib15 article-title: RING domain-mediated interaction is a requirement for MDM2′s E3 ligase activity publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-1313 – volume: 18 start-page: 1239 year: 2012 ident: 2022061706173794000_bib26 article-title: MDM4 is a key therapeutic target in cutaneous melanoma publication-title: Nat Med doi: 10.1038/nm.2863 – volume: 137 start-page: 609 year: 2009 ident: 2022061706173794000_bib1 article-title: Modes of p53 regulation publication-title: Cell doi: 10.1016/j.cell.2009.04.050 – volume: 124 start-page: 4976 year: 2014 ident: 2022061706173794000_bib36 article-title: Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination publication-title: J Clin Invest doi: 10.1172/JCI75667 – volume: 100 start-page: 883 year: 2007 ident: 2022061706173794000_bib3 article-title: p53 modulation of the DNA damage response publication-title: J Cell Biochem doi: 10.1002/jcb.21091 – volume: 10 start-page: 1089 year: 2009 ident: 2022061706173794000_bib24 article-title: Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production publication-title: Nat Immunol doi: 10.1038/ni.1777 – volume: 13 start-page: 83 year: 2013 ident: 2022061706173794000_bib8 article-title: MDM2, MDMX and p53 in oncogenesis and cancer therapy publication-title: Nat Rev Cancer doi: 10.1038/nrc3430 |
SSID | ssj0005105 |
Score | 2.3620987 |
Snippet | Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which... Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers.Mdm2 and Mdmx, both... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2897 |
SubjectTerms | Animals Cancer Cell Cycle Proteins Cell Line Cell Line, Tumor Cytoplasm Cytoplasm - metabolism HEK293 Cells Humans Localization MDM2 protein Melanoma Melanoma - metabolism Melanoma, Cutaneous Malignant Mice Myc protein Nuclear Proteins - metabolism Nuclei p53 Protein Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins c-mdm2 - metabolism Repressors Rodents Skin Neoplasms - metabolism Tumor Suppressor Protein p53 - metabolism Tumorigenesis Ubiquitin-protein ligase Ubiquitin-Protein Ligases - metabolism Ubiquitination Ubiquitination - physiology |
Title | Peli1 Modulates the Subcellular Localization and Activity of Mdmx |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29523541 https://www.proquest.com/docview/2047591878 https://www.proquest.com/docview/2012912819 https://pubmed.ncbi.nlm.nih.gov/PMC5984691 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiPcWFhQkbquUOrFj51hVu6yg2wXRSr1FsWNrK3VTtLQC8RP41cw4zqN0xesSRXk5mvk8nrE_zxDyWgrLbaFtmPKiCJniPJTKilAom6QF46lxaRfPp8nZnL1b8EWv96PDWtpu1EB_v3Ffyf9oFa6BXnGX7D9otvkoXIBz0C8cQcNw_CsdfzCrJcVyZliDC3M1gM7BEuBkvGOXTnCg8hst3SrBSPtiEUh8Ka6-dV3TMer_-thn_7l0y7sVT8PZkdVq0Jk1mPj96V_Nso39sT7z8cVVzZF3ddnX4diTfj9tGxy-3Tpqn3_XzzlQ2XKjOjR_sD8dCDlWpP_TmjS4R-dEjyPkrCrWMzCtyRWsSipZ22Qhu9ijXQsrKz6vH62jtGLF7o8EXFbUyarBwXg0DWFAjrkfdHYyb08vstP5ZJLNThazW-R2BCEH2sz3H9vM89zTYesP-t1g0MybGxvZ9XP2gpdfObgdp2Z2n9zz0UgwqqD1gPRM-ZDcOfd8i0dk5BAWNAgLAGFBB2FBF2EBICyoERasbYAIe0zmpyez8Vnoi26EGnzTTZjTJIegVgoFkXdUaE4TGyUqLyCQxkVhK7hKmbaxFoKKXNsolZEYpiYyCfR0Ez8hB-W6NIck0LHKqcyF1lowwyJl5TAdFkqwPGe0KPqE1SLKtM9Ij4VRVpmLTLlEZoTMULIZSDajIkPJ9smgee1zlZLlTy8c1fLPfO_9kkVDzHRJpZB98qq5DbYVJZiXZr3FZ8AbdkvNffK0UlfTIogiijmDj4sdRTYPYN723Tvl8tLlb-cpOP0pffb733pO7rZd74gcbK635gU4wBv10iHzJ5Mpq1s |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Peli1+Modulates+the+Subcellular+Localization+and+Activity+of+Mdmx&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Li%2C+Dawei&rft.au=Tavana+Omid&rft.au=Shao-Cong%2C+Sun&rft.au=Gu%2C+Wei&rft.date=2018-06-01&rft.pub=American+Association+for+Cancer+Research%2C+Inc&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=78&rft.issue=11&rft.spage=2897&rft.epage=2910&rft_id=info:doi/10.1158%2F0008-5472.CAN-17-3531&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |